Queensland Webinar Presentations
Details below for events scheduled 11.06.20 and 25.06.20
New Zealand IP Update
| DATE: | Thursday, 11 June 2020 |
|---|---|
| TIME: | 1.00 pm (AEST) (NSW, QLD, VIC, TAS) Presentation
3.00 pm New Zealand Concludes 2.00 pm AEST |
| ACCESS: | Presentation by Webinar via Zoom (link to be shared with registrants)
(Registered members will receive details by email prior to the event enabling access to the webinar) |
| TOPIC: | New Zealand – IP Update
A comparative look at key developments in NZ and AU:
Time will be made for questions and discussion. |
| SPEAKERS |
Clive Elliott QC
Barrister, Shortland Chambers, Auckland |
|
COST: |
FREE for IPSANZ Members $50.00 Non-Members (Incl. $4.55 GST) |
| CPD: | 1 CPD point – Substantive Law |
| RSVP: | Thursday, 4 June 2020 |
Damages in Pharmaceutical Patent Cases
| DATE: | Thursday, 25 June 2020 |
|---|---|
| TIME: | 5.00 pm (AEST) (NSW, QLD, VIC, TAS)
3.00 pm Western Australia Concludes 6.00 pm AEST |
| ACCESS: | Presentation by Webinar via Zoom (link to be shared with registrants)
(Registered members will receive details by email prior to the event enabling access to the webinar) |
| TOPIC: | A formidable undertaking: Recent developments and the way forward on the undertaking as to damages in pharmaceutical patent cases
In the recent decision of the Federal Court in Commonwealth v Sanofi, the Court found that the Commonwealth’s application for compensation failed. The panel will discuss why the application failed, consider the implications of that decision and compare and contrast the decision with the 2018 decision in Sigma v Wyeth, a claim for compensation on the undertaking by generic pharmaceutical manufacturers. Time will be made for questions and discussion. |
| SPEAKERS |
Patrick Flynn SC is a Sydney based Senior Counsel. He was called to the Bar in 2005 and appointed Senior Counsel in 2019. Patrick has practised extensively in intellectual property and acted as (then) junior counsel for Alphapharm in proceedings against Wyeth involving a claim on an undertaking as to damages given by Wyeth in return for an interlocutory injunction to restrain the supply of venlafaxine products in Australia.
James Sharkey is the CEO of Seekwell, an Australian pharmaceutical company that focuses on specialty medicines. James was formerly in house counsel at Sandoz and AstraZeneca, before moving into senior commercial and executive roles. Kim O’Connell is a partner at King & Wood Mallesons. She specialises in intellectual property and life sciences matters. Kim acted for Alphapharm in claiming compensation pursuant to an undertaking as to damages given by Wyeth in return for an interlocutory injunction to restrain the supply of venlafaxine products. |
|
COST: |
FREE for IPSANZ Members $50.00 Non-Members (Incl. $4.55 GST) |
| CPD: | 1 CPD point – Substantive Law |
| RSVP: | Thursday, 18 June 2020 |
In light of the evolving situation with COVID-19, event are being offered by way of webinar only. This option will still allow members to ‘attend’ the session online and obtain the relevant CPD point.
Registration for the webinar remains open to members and all registrants are able to access the webinar online at a place of their convenience. Details to access the webinar will be sent to registrants prior to the commencement of the session.
This change in format is for many of us, a trial and we greatly appreciate your patience and continued support.